Neuroblastoma. Elizabeth Roberts. Data Coordinator CIBMTR Data Managers Mentor. Tandem Meeting February 18
|
|
- Arron Murphy
- 6 years ago
- Views:
Transcription
1 Neuroblastoma Elizabeth Roberts Data Coordinator CIBMTR Data Managers Mentor Tandem Meeting February 18
2 Objectives Know what neuroblastoma is, how it is diagnosed, and how it is treated Complete form 2026: Neuroblastoma Pre-HSCT Data Complete form 2126: Neuroblastoma Post-HSCT Data
3 About My Center Pediatric Center, performing average of 100 transplants per year. First transplant performed in 1981 Three Data Coordinators, specializing in disease-specific areas We use Epic for our electronic records
4 What Is Neuroblastoma? Starts in very early forms of nerve cells (neuroblasts) of the sympathetic nervous system Neuro = nerves Blastoma = cancer
5 Common Neuroblastoma Sites Adrenal glands Abdomen (nonadrenal) Chest Pelvis Neck
6 Neuroblastoma Statistics 8-10% of all childhood cancers ~8 children per million per year under age of 15 diagnosed Median age of diagnosis is 22 month More than 95% of cases are detected by 10 years of age
7 How Is Neuroblastoma Diagnosed? Blood and urine catecholamine tests Imaging tests Biopsy of tumor site Bone marrow aspiration and biopsy
8 Catecholamine Tests Detected in more than 85% of patients with NBL Homovanillic Acid (HVA) Vanillymandelic Acid (VMA)
9 Imaging Tests CT scans usually abdomen, pelvis, and chest MRI scans usually brain and spine MIBG scans preferred by many doctors as the standard test PET scans
10 Biopsy Tissue is often needed to obtain all data required for risk-group assignment and treatment stratification in COG clinical trials
11 Bone Marrow Aspiration/Biopsy Determine extent of disease/staging
12 Neuroblastoma Staging INSS System Stage 1: Localized tumor with complete gross excision; lymph nodes negative for tumor microscopically Stage 2A: Localized tumor with incomplete resection; lymph nodes negative Stage 2B: Localized tumor with or without complete resection; ipsilateral lymph nodes positive Stage 3: Unresectable unilateral tumor infiltrating across the midline; or localized unilateral tumor with contralateral positive lymph nodes Stage 4: Disseminated disease (except 4S) Stage 4S: Localized primary tumor with dissemination limited to skin, liver and/or marrow (<10%) (infants < 1yr)
13 Neuroblastoma and the MYCN Oncogene Amplification of MYCN occurs in ~20% of primary untreated NB tumors, and is associated with: Advanced stage disease (Science, 1984) Rapid tumor progression and poor prognosis (N. Engl. J. Med., 1985) High levels of MYCN expression (Science, 1984)
14 What Therapies Do We Use to Treat Neuroblastoma? Surgery/biopsy Chemotherapy Second look surgery ASCT Radiation therapy Cis-Retinoic therapy Immunotherapy
15 Surgery Remove as much tumor as possible Dependent on proximity to vital structures or blood vessels Chemotherapy may be used to shrink the tumor first
16 Chemotherapy Commonly used when metastases involved May be before (neoadjuvant) or after (adjuvant) surgery Most common drugs: carboplatin (or cisplatin), cyclophosphamide, doxorubicin, and etoposide in cycles
17 Stem Cell Transplant High-risk patients High doses of chemotherapy are effective in treating NBL, but also severely damage bone marrow Need to give stem cells to replace those that were lost Use patient s own cells (autologous transplant)
18 Radiation Therapy External Beam Aimed at tumor only Can be used to shrink tumor before surgery Sometimes part of treatment regiment before stem cell transplant MIBG Therapy Delivers radiation directly to tumor via blood stream
19 Retinoid Therapy Related to Vitamin A Differentiating Agents Help cancer cells differentiate into normal cells Currently use 13-cis-retinoic acid
20 Immunotherapy Typically used in high-risk patients Helps immune system recognize and destroy cancer cells more effectively Monoclonal antibodies given with cytokines
21 Filling Out the Forms Form 2026 is for Pre-HSCT data Form 2126 is for Post-HSCT data
22 Form 2026: Clinical and Laboratory Characteristics at Diagnosis Diagnosis Date - Pathology
23 Form 2026: Clinical and Laboratory Characteristics at Diagnosis
24 Form 2026: Clinical and Laboratory Characteristics at Diagnosis
25 Form 2026: Clinical and Laboratory Characteristics at Diagnosis Use pathology report for sites of primary disease Metastases Radiographic tests in Epic, Radiology tab Biopsies Pathology tab Shimada Classification Pathology report
26 Form 2026: Laboratory Values at Diagnosis of Neuroblastoma HVA and VMA in Urine Chemistry. We send ours out
27 Form 2026: Laboratory Values at Diagnosis of Neuroblastoma N-myc amplification - Supplementary pathology report
28 Form 2026: Laboratory Values at Diagnosis of Neuroblastoma
29 Form 2026: Laboratory Values at Diagnosis of Neuroblastoma Cytogenetic Analysis Our center tends to not perform these on NBL patients INSS most centers use this, but if yours uses POG or Evans, report those. Noted on supplemental report
30 Form 2026: Laboratory Values at Diagnosis of Neuroblastoma
31 Form 2026: Laboratory Values at Diagnosis of Neuroblastoma Surgery Radiotherapy Chemotherapy Oncology road maps Best Response Pathology reports
32 Form 2026: Line of Therapy
33 Form 2026: Disease Status Immediately Prior to Preparative Regimen
34 Form 2126: Disease Assessment at Time of Best Response to HSCT Planned Therapy Radiotherapy End of Treatment Note Retinoids Immunotherapy Chemotherapy
35 Form 2126: Disease Assessment at Time of Best Response to HSCT
36 Form 2126: Disease Assessment at Time of Best Response to HSCT
37 Form 2126: Disease Assessment at Time of Best Response to HSCT
38 Form 2126: Disease Assessment at Time of Best Response to HSCT
39 Form 2126: Disease Assessment at Time of Best Response to HSCT Recurrence/Progression Pathology Treatment for persistent, progressive, or recurrent disease
40 References American Cancer Society. Cancer Facts and Figures Atlanta, Ga: American Cancer Society; Cheung NK, Dyer MA. Neuroblastoma: Developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer. 2013; 13: Grupp SA, Dvorak CC, Nieder ML, et.al. Children s Oncology Group s 2013 blueprint for research: Stem cell transplantation. Pediatr Blood Cancer. 2013; 60: National Cancer Institute. Pysician Data Query. Neuroblastoma Treatment Accessed at althprofessional on 2/4/16. Yu AL, Gilman AL, Ozkaynak MF, et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010; 363:
41 Questions?
Wilms Tumor and Neuroblastoma
Wilms Tumor and Neuroblastoma Wilm s Tumor AKA: Nephroblastoma the most common intra-abdominal cancer in children. peak incidence is 2 to 3 years of age Biology somatic mutations restricted to tumor tissue
More informationDr.Dafalla Ahmed Babiker Jazan University
Dr.Dafalla Ahmed Babiker Jazan University Brain tumors are the second commonest malignancy in children Infratentorial tumors are more common As a general rule they do not metastasize out of the CNS, but
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Solid Tumors of File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_solid_tumors_childhood
More informationTHORACIC MALIGNANCIES
THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,
More informationCurrent update on diagnosis and management of neuroblastoma
Leading Article Current update on diagnosis and management of neuroblastoma Julius Scott 1 Sri Lanka Journal of Child Health, 2016; 45(4): 241-246 DOI: http://dx.doi.org/10.4038/sljch.v45i4.8182 (Key words:
More informationHodgkin's Lymphoma. Symptoms. Types
Hodgkin's lymphoma (Hodgkin's disease) usually develops in the lymphatic system, a part of the body's immune system. This system carries disease-fighting white blood cells throughout the body. Lymph tissue
More information재발성혹은불응성신경모세포종환자에서의활성화 T- 림프구세포치료 2 예
Clinical Pediatric Hematology-Oncology Volume 25 ㆍ Number 2 ㆍ October 2018 CASE REPORT 재발성혹은불응성신경모세포종환자에서의활성화 T- 림프구세포치료 2 예 최정윤ㆍ안홍율ㆍ홍경택ㆍ홍채리ㆍ강형진ㆍ신희영 서울대학교의과대학소아과학교실, 서울대학교암연구소 Two Cases of Adjuvant Immunotherapy
More informationPDF created with pdffactory Pro trial version
Neuroblastoma Tumor derived from neural crest cell that form the sympathetic ganglia&adrenal medulla. Causes *unknown. *familial neuroblastoma has been reported but is rare. * The incidence is 1:100,000
More informationSurgical Outcomes of Patients with Neuroblastoma in a Tertiary Centre in Hong Kong: A 12-year Experience
HK J Paediatr (new series) 2009;14:186-193 Surgical Outcomes of Patients with Neuroblastoma in a Tertiary Centre in Hong Kong: A 12-year Experience IHY CHAN, KKY WONG, GCF CHAN, PKH TAM Abstract Key words
More informationOncologist. The. Neuro-Oncology. Case Report: An Unusual Case of Adrenal Neuroblastoma in Pregnancy
The Oncologist Neuro-Oncology Case Report: An Unusual Case of Adrenal Neuroblastoma in Pregnancy MARWAN M. REFAAT, a SHEREENE Z. IDRISS, b LAWRENCE S. BLASZKOWSKY a,c a Department of Medicine, b Department
More informationEffective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,
Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the
More informationResearch Article Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience
Sarcoma, Article ID 375151, 6 pages http://dx.doi.org/10.1155/2014/375151 Research Article Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience Henry J. Conter, 1 Vancheswaran
More informationSOLID TUMOURS IN CHILDHOOD
SOLID TUMOURS IN CHILDHOOD Fareed Omar Paediatric Oncology Steve Biko Academic hospital Introduction 1 Introduction Lymphomas and Leukemias make up about 40% of all childhood Cancers (Systemic cancers)
More informationUpdate in Pediatric Oncology. Pediatric Leukemia 9/21/2016. Objectives. Disclosure. Classification
Objectives Update in Pediatric Oncology Katie Bruce, PharmD, BCPPS Pharmacy Clinical Specialist Pediatric Oncology and BMT The Children s Hospital at TriStar Centennial Review newest therapies in pediatric
More informationUpdate on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD
Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD Section of Pediatric Radiology C.S. Mott Children s Hospital University of Michigan ethans@med.umich.edu Disclosures No relevant
More informationDr Marty Campbell Paediatric Oncologist Royal Children's Hospital, Melbourne. FRACP lecture series Oct 2014
Dr Marty Campbell Paediatric Oncologist Royal Children's Hospital, Melbourne FRACP lecture series Oct 2014 Background Neuroblastoma (NB) is the most common solid tumour outside the CNS in children 6-10%
More informationAdrenal masses in infancy and childhood: A clinical and radiological overview M. Mearadji
Adrenal masses in infancy and childhood: A clinical and radiological overview M. Mearadji International Foundation for Pediatric Imaging Aid Introduction Neoplastic adrenal masses usually originate from
More informationSELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m.
SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, 2018 10:00 12:10 p.m. Staging Susan E. Sharp, MD 1. In the International Neuroblastoma Risk Group Staging
More informationPediatric Oncology. Vlad Radulescu, MD
Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common
More informationLYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center
LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells
More informationAll India Institute of Medical Sciences, New Delhi, INDIA. Department of Pediatric Surgery, Medical Oncology, and Radiology
All India Institute of Medical Sciences, New Delhi, INDIA Department of Pediatric Surgery, Medical Oncology, and Radiology Clear cell sarcoma of the kidney- rare renal neoplasm second most common renal
More informationLymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system.
Scan for mobile link. Lymphoma Lymphoma is a cancer that develops in the white blood cells of the lymphatic system. Symptoms may include enlarged lymph nodes, unexplained weight loss, fatigue, night sweats
More informationClinical Management Guideline for Small Cell Lung Cancer
Diagnosis and Staging: Key Points 1. Ensure a CT scan that is
More informationNeuroblastoma Early Detection, Diagnosis, and Staging
Neuroblastoma Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be noticed,
More informationForm 2023 R2.0: Ovarian Cancer Pre-HSCT Data
Key Fields Sequence Number Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Today's Date: - - Date of HSCT for which this form is being completed: - - HSCT type: (check all that apply) Autologous
More informationDoppler ultrasound of the abdomen and pelvis, and color Doppler
- - - - - - - - - - - - - Testicular tumors are rare in children. They account for only 1% of all pediatric solid tumors and 3% of all testicular tumors [1,2]. The annual incidence of testicular tumors
More informationClinical Policy: Tandem Transplant
Clinical Policy: Reference Number: PA.CP.MP.162 Effective Date: 09/18 Last Review Date: 09/18 Coding Implications Revision Log Description A tandem transplant, (also known as a sequential or double transplant),
More information4/9/18. Disclosure Information. Objectives. Overview of Neuroblastoma Management. I have no disclosures.
Overview of Neuroblastoma Management Lauren Martino, RN, MSN, CPNP Pediatric Surgery Nurse Practitioner Memorial Sloan-Kettering Cancer Center Disclosure Information I have no disclosures. Objectives Describe
More informationCOG-ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Page 1 of 10 COG-ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma FAST FACTS Eligibility Reviewed and Verified By MD/DO Date RN
More informationNeuroblastoma: experience from National University Health System, Singapore ( )
Singapore Med J 2012; 53(1) : 19 Neuroblastoma: experience from National University Health System, Singapore (1987 2008) Tan C 1, BA, Sabai SM 2, MBBS, Tin AS 3, MBBS, MMed, Quah TC 4, MBBS, MMed, Aung
More informationIntrarenal Extension. sinus
Intrarenal Extension into sinus Document Capsular Penetration sinus 16 Pediatric Renal Tumor Staging Stage I Limited to Kidney & Completely Resected Intact Renal Capsule No Previous Rupture or Biopsy Renal
More informationNOTE: This policy is not effective until March 1, To view the current policy, click here.
Medical Policy Manual Topic: Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood Date of Origin: May 2010 Section: Transplant Last Reviewed Date: August 2012 Policy No: 45.37 Effective
More informationThymic Tumors. Feiran Lou MD. MS. Kings County Hospital Department of Surgery
Thymic Tumors Feiran Lou MD. MS. Kings County Hospital Department of Surgery Case HPI 53 yo man referred from OSH for anterior mediastinal mass. Initially presented with leg weakness and back pain for
More informationPrior Authorization Review Panel MCO Policy Submission
Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review. Policies submitted without this form will not be considered for review.
More informationState of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center
State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech
More informationCCG-3891 LONG TERM OUTCOME FOR CHILDREN WITH HIGH RISK NEUROBLASTOMA Additional Information on Corrected Overall Survival Results April 10, 2014
Group Chair Peter C. Adamson, M.D. adamson@email.chop.edu Group Vice Chair Susan Blaney, M.D. smblaney@txch.org Chief Operating Officer Elizabeth O Connor, M.P.H. econnor@childrensoncology group.org Chief
More informationLarge cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s
Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated
More informationNAACR Treatment Webinar Quiz 1
NAACR Treatment Webinar Quiz 1 1. Which of the following would NOT be considered cancer-directed treatment? a. Hemicolectomy b. Incisional biopsy c. Whole breast radiation d. MRI e. All of the above f.
More informationHematopoietic Cell Transplantation for Solid Tumors of Childhood
Medical Policy Manual Transplant, Policy No. 45.37 Hematopoietic Cell Transplantation for Solid Tumors of Childhood Next Review: August 2018 Last Review: December 2017 Effective: January 1, 2018 IMPORTANT
More informationHematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood
Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood Policy Number: Original Effective Date: MM.07.021 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO 12/16/2016 Section:
More informationRadiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationHematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood
Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood Policy Number: Original Effective Date: MM.07.021 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO 05/24/2013 Section:
More informationNeuroblastoma Joseph Junewick, MD FACR
Neuroblastoma Joseph Junewick, MD FACR 03/18/2011 History 15 month old with anemia. Diagnosis Neuroblastoma Discussion Neuroblastic tumors derive from primordial neural crest cells destined for sympathetic
More informationSurgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer
Ovarian cancer Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru Suitable candidates for neo-adjuvant
More informationProceedings of Congress
HK J Paediatr (new series) 2012;17:123-129 Proceedings of Congress 2011 Annual Scientific Meeting: Hong Kong Paediatric Haematology and Oncology Study Group 26 March 2011 Acute Lymphoblastic Leukaemia
More informationAcute: Symptoms that start and worsen quickly but do not last over a long period of time.
Cancer Glossary Acute: Symptoms that start and worsen quickly but do not last over a long period of time. Adjuvant therapy: Treatment given after the main treatment. It usually refers to chemotherapy,
More informationMarshall T Bell Research Resident University of Colorado Grand Rounds Nov. 21, 2011
Marshall T Bell Research Resident University of Colorado Grand Rounds Nov. 21, 2011 Most common form of cancer in adults ages 25-29 3-5% of skin cancers but 65-75% of deaths Most common metastasis to small
More informationEVIDENCE BASED MANAGEMENT FOR Nueroblastoma
EVIDENCE BASED MANAGEMENT FOR Nueroblastoma Introduction : Neuroblastoma and related neoplasms arise from those neural crest cells which differentiate in cells of the sympathetic ganglia and adrenal medulla.neuroblastoma
More information2-Deoxyglucose and Retinoic Acid as Potential Adjuvants in Combination with Molecularly Targeted Radiotherapy in Neuroblastoma
2-Deoxyglucose and Retinoic Acid as Potential Adjuvants in Combination with Molecularly Targeted Radiotherapy in Neuroblastoma Cancer Health Disparities Summit 2008 Cancer Therapeutics and Radiopharmaceutical
More informationAdjuvant therapy for thyroid cancer
Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women
More informationMediastinal Staging. Samer Kanaan, M.D.
Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor
More informationIndolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital
Indolent Lymphomas Dr. Melissa Toupin The Ottawa Hospital What does indolent mean? Slow growth Often asymptomatic Chronic disease with periods of relapse (long natural history possible) Incurable with
More informationFAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated
Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly
More informationThe Role of ploidy in neuroblastoma. Michael D. Hogarty, MD Division of Oncology Children s Hospital of Philadelphia
The Role of ploidy in neuroblastoma Reprinted from NB Journal Summer Issue 2003 Children s Neuroblastoma Cancer Foundation Michael D. Hogarty, MD Division of Oncology Children s Hospital of Philadelphia
More informationTrimodality Therapy for Muscle Invasive Bladder Cancer
Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,
More informationWorkshop LA RADIOTERAPIA DEI TUMORI RARI I TIMOMI : INDICAZIONI
XXI CONGRESSO NAZIONALE AIRO Genova, 19-22 novembre 2011 Workshop LA RADIOTERAPIA DEI TUMORI RARI I TIMOMI : INDICAZIONI PIERA NAVARRIA Unità Operativa di Radioterapia e Radiochirurgia Humanitas Cancer
More informationOpdivo. Opdivo (nivolumab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.53 Subsection: Antineoplastic Agents Original Policy Date: January 16, 2015 Subject: Opdivo Page:
More informationLymphoma. What is cancer? What are signs that my cat has lymphoma. How is Lymphoma diagnosed?
What is cancer? Lymphoma Cancer is the uncontrolled growth of a small population of abnormal cells. These abnormal cells form by a mutation during the normal division cycle and are able to escape detection
More information- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer
Thyroid Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: 1. Lenvina is the first line therapy with powerful durable response and superior PFS in pts with RAI-refractory disease.
More informationBLADDER CANCER CONTENT CREATED BY. Learn more at
BLADDER CANCER CONTENT CREATED BY Learn more at www.health.harvard.edu TALK TO YOUR DOCTOR Table of Contents WHAT IS BLADDER CANCER? 4 TYPES OF BLADDER CANCER 5 GRADING AND STAGING 8 TREATMENT OVERVIEW
More informationDifferent Types of Cancer
Different Types of Cancer Cancer can originate almost anywhere in the body. Sarcomas (connective tissue) Ø arise from cells found in the supporting tissues of the body such as bone, cartilage, fat, connective
More informationContinuing Education Exam Pediatric Tumor Boards, Volume II
Please Print or Type: Name: Address: Continuing Education Exam Pediatric Tumor Boards, Volume II City: State: Zip: Social Security #: Phone: Highest Degree: Payment: Check enclosed I am claiming CME credit
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationLUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University
LUNG CANCER Agnieszka Słowik, MD Department of Oncology, University Hospital in Cracow Jagiellonian University Epidemiology Most common malignancy worldwide Place of lung cancer among other malignancies
More informationNICaN Testicular Germ Cell Tumours SACT protocols
Reference No: Title: Author(s) Ownership: Approval by: Systemic Anti-Cancer Therapy (SACT) Guidelines for Germ Cell Tumours Dr Audrey Fenton Consultant Medical Oncologist, Dr Vicky Coyle Consultant Medical
More informationThe International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies
More informationRadiopharmaceutical Therapy with Radium-223 and 131 I-mIBG
Radiopharmaceutical Therapy with Radium-223 and 131 I-mIBG Aaron C. Jessop, MD, MBA Associate Professor of Clinical Radiology Director of Nuclear Medicine and PET Vanderbilt University Medical Center Target
More informationSlide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology
Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new
More informationMolly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010
LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical
More informationUpdate on Small Cell Lung Cancer
Welcome to Master Class for Oncologists Session 4: 10:00 AM - 10:45 AM San Francisco, CA October 23, 2009 Speaker: Bruce E. Johnson, MD Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical
More informationWhat is head and neck cancer? How is head and neck cancer diagnosed and evaluated? How is head and neck cancer treated?
Scan for mobile link. Head and Neck Cancer Head and neck cancer is a group of cancers that start in the oral cavity, larynx, pharynx, salivary glands, nasal cavity or paranasal sinuses. They usually begin
More informationNEUROBLASTOMA IS the most common extracranial
Correlation of Early Metastatic Response by 123 I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma By Katherine K. Matthay, Veronique Edeline,
More informationHematopoietic Stem-Cell Clinical Coverage Policy No: 11A-15 Transplantation for Solid Amended Date: October 1, 2015 Tumors of Childhood
Hematopoietic Stem-Cell Clinical Coverage Policy No: 11A-15 Transplantation for Solid Amended Date: October 1, 2015 Tumors of Childhood Table of Contents 1.0 Description of the Procedure, Product, or Service...
More informationSpecialist Referral Service Willows Information Sheets. Cancer in cats and dogs: Assessment of the patient
Specialist Referral Service Willows Information Sheets Cancer in cats and dogs: Assessment of the patient Cancer in cats and dogs: Assessment of the patient Cancer is common in human and veterinary medicine.
More informationCONTRACTING ORGANIZATION: Children s Hospital Los Angeles Los Angeles, CA 90027
AD Award Number: TITLE: Studies of the Tumor Microenvironment in Pathogenesis of Neuroblastoma PRINCIPAL INVESTIGATOR: Shahab Asgharzadeh, M D CONTRACTING ORGANIZATION: Children s Hospital Los Angeles
More informationCOLORECTAL CANCER STAGING in 2010
COLORECTAL CANCER STAGING in 2010 Robert A. Halvorsen, MD, FACR MCV Hospitals / VCU Medical Center Richmond, Virginia I do not have any relevant financial relationships with any commercial interests COLON
More informationBreast Cancer Diagnosis, Treatment and Follow-up
Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce
More informationWHAT ARE PAEDIATRIC CANCERS
WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600
More informationOutcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
original article Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma David L. Baker, M.D., Mary L. Schmidt, M.D., Susan L. Cohn, M.D., John M. Maris, M.D., Wendy B. London, Ph.D., Allen
More informationColorectal Cancer Treatment
Scan for mobile link. Colorectal Cancer Treatment Colorectal cancer overview Colorectal cancer, also called large bowel cancer, is the term used to describe malignant tumors found in the colon and rectum.
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Approach to Abdominal Mass Part 2. These podcasts are designed to give medical students an overview of key topics in
More informationCancer Registry Report. Cancer Focus: Melanoma
Cancer Registry Report Cancer Focus: Melanoma In 2005, nearly 60,000 patients were diagnosed with melanoma, resulting in about 7800 deaths Fortunately, melanoma is often diagnosed in an early stage when
More informationSarcomas. Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center
Sarcomas Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center Aaron Sugalski, DO Associate Professor of Pediatric Hematology/Oncology Medical Director, UHS Pediatric Blood and Cancer
More informationCommon Childhood Tumors. Денис Овечкін
Common Childhood Tumors Денис Овечкін 2016 Зміст 3 Зміст Common Childhood Tumors RHABDOMYOSARCOMA Etiology and pathogenesis Epidemiology Clinical presentation Clinical Group Outcomes LIPOMATOUS TUMORS
More informationNON HODGKINS LYMPHOMA: AGGRESSIVE Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)
NON HODGKINS LYMPHOMA: AGGRESSIVE Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematologist, University of Calgary) and
More informationMANAGEMENT OF CA HYPOPHARYNX
MANAGEMENT OF CA HYPOPHARYNX GENERAL TREATMENT RECOMMENDATIONS BASED ON HYPOPHARYNX TUMOR STAGE For patients presenting with early-stage definitive radiotherapy alone or voice-preserving surgery are viable
More informationSTEP 2: Identification of recurrence (local, regional or distant metastases) based on electronic health record algorithm using automated databases:
Appendix 1. Specifications for identifying subsequent breast cancer STEP 1: Identification of second primary breast cancer Identification based on key variables from Cancer Registry including date of diagnosis;
More informationOne Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases
One Day BMT Course by Thai Society of Hematology Management of Graft Failure and Relapsed Diseases Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital
More informationBrain Tumors. What is a brain tumor?
Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain
More informationWilms Tumour A brief note for the parents
Wilms Tumour A brief note for the parents By Dr. Abid Qazi!1 PARENT S GUIDE FACTSHEET Cancer is not an incurable disease any more in many circumstances. The key for cure is early diagnosis. However, it
More informationFAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated
Page 1 of 5 COG-ANBL1531: A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk (NBL) (IND# 134379) FAST FACTS
More informationNon-Hodgkin lymphoma
Non-Hodgkin lymphoma Non-Hodgkin s lymphoma Definition: - clonal tumours of mature and immature B cells, T cells or NK cells - highly heterogeneous, both histologically and clinically Non-Hodgkin lymphoma
More informationPolicy. Medical Policy Manual Approved Revised: Do Not Implement until 6/30/2019. Nivolumab
Medical Manual Approved Revised: Do Not Implement until 6/30/2019 Nivolumab NDC CODE(S) 00003-3772-XX Opdivo 40 MG/4ML SOLN (B-M SQUIBB U.S. (PRIMARY CARE)) 00003-3774-XX Opdivo 100 MG/10ML SOLN (B-M SQUIBB
More informationPresence of Differentiating Neuroblasts in Bone Marrow is a Favorable Prognostic Factor for Bone Marrow Metastatic Neuroblastoma at Diagnosis
Original Article Diagnostic Hematology Ann Lab Med 2013;33:89-96 ISSN 2234-3806 eissn 2234-3814 Presence of Differentiating Neuroblasts in Bone Marrow is a Favorable Prognostic Factor for Bone Marrow Metastatic
More information